In late May 2026, Thermo Fisher Scientific showcased its new Thermo Scientific Orbitrap Tribrid Apex and Orbitrap Excedion mass spectrometers at the ASMS Conference, highlighting faster, more sensitive multiomics and complex drug development analysis alongside AI-enabled software and its Olink proteomics platform. By pairing these Orbitrap systems with recent AI-focused software acquisitions and expanded bioanalytical labs in Sweden, Thermo Fisher is deepening its role across the entire drug...

HSBC Downgrades Thermo Fisher Scientific (TMO)

If you are wondering whether Thermo Fisher Scientific at around US$494 per share looks attractively priced or stretched, the starting point is to understand what the current market is implying about its future. The stock has been volatile recently, with a 10.2% gain over the past week, a 5.3% gain over the past month, a decline of 16.6% year to date, and a 25.1% gain over the past year, which together suggest shifting views on its prospects and risk profile. Recent headlines have focused on...